Savant Neglected Diseases - Benznidazole Program's Unit Acquisition

Savant Neglected Diseases - Benznidazole Program raised a round of funding on December 03, 2015. Investors include Humanigen.

Savant Neglected Diseases, founded in 2009, develops pharmaceutical products that improve health, maintain wellness and prevent disease. The company identifies undervalued opportunities to create inno…

Articles about Savant Neglected Diseases - Benznidazole Program's Unit Acquisition: